Further assessments of specific subset of T-cells, such as CD3 + , CD4 + , CD8 + and FOXP3 + in tumor tissues could be useful, as these subsets have been shown to predict survival outcome [29–31]. This evidence concerns the gene FOXP3 and neoplasm.